The tech giant Microsoft announced Thursday that it is partnering with Seattle biotech company Adaptive Biotechnologies on a years-long project to build a universal blood test that can screen for dozens or even hundreds of diseases at a time, all by decoding the information in your immune system.
As part of the deal, Microsoft is investing an undisclosed sum in Adaptive and is offering the company cloud computing and machine learning services. The combined value of those two is in the “hundreds of millions of dollars,” Adaptive CEO Chad Robins told GeekWire. The project is part of Microsoft's Healthcare NExT program, which aims to put Microsoft technologies to work on solving problems in healthcare.
If the project is a success, it would be a radical change to how we diagnose diseases from cancer to multiple sclerosis and would mark a new era for health technology.
Read the full article on GeekWire.